Copyright
©The Author(s) 2018.
World J Clin Oncol. Nov 10, 2018; 9(7): 123-132
Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.123
Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.123
Breast cancer (n = 48) | Benign pathology (n = 26) | P value1 | |
Mean age (yr) | 57.79 ± 14.13 (range: 31-85) | 32.54 ± 11.63 (range: 14-60) | 0.000 |
Menarche (yr) | 12.42 ± 1.67 (range: 9-16) | 12.62 ± 1.69 (range: 9-17) | 0.763 |
Term pregnancy | 2.63 ± 2.27 (range: 0-11) | 1.50 ± 1.55 (range: 0-5) | 0.066 |
Sexual partners | 1.98 ± 1.15 (range: 0-5) | 1.76 ± 1.09 (range: 1-3) | 0.750 |
Oral contraceptives | 47.92% | 65.38% | 0.352 |
Tobacco | 50.00% | 11.53% | 0.002 |
Alcohol | 47.92% | 46.15% | 0.678 |
Breast cancer family history | 37.50% | 19.23% | 0.199 |
- Citation: Fernandes A, Pesci-Feltri A, García-Fleury I, López M, Guida V, De Macedo M, Correnti M. Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes. World J Clin Oncol 2018; 9(7): 123-132
- URL: https://www.wjgnet.com/2218-4333/full/v9/i7/123.htm
- DOI: https://dx.doi.org/10.5306/wjco.v9.i7.123